(Q40579791)

21 September 2017

title

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression (English)

1 reference

21 September 2017

3

1 reference

21 September 2017

Kim-Lien Nguyen

1

0 references

Stephan Bour

object named as

Stephan Bour

7

0 references

author name string

Manuel llano

2

1 reference

21 September 2017

Eri Miyagi

4

1 reference

21 September 2017

Eric M Poeschla

5

1 reference

21 September 2017

Klaus Strebel

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

319

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

163-175

1 reference

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

21 September 2017

cites work

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

7 January 2021

The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

HIV accessory proteins: multifunctional components of a complex system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Regulation by HIV Rev depends upon recognition of splice sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Selective extraction of polyoma DNA from infected mouse cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

MRNA stability and the control of gene expression: implications for human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

High-level periplasmic expression in Escherichia coli using a eukaryotic signal peptide: importance of codon usage at the 5' end of the coding sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Rev protein and its cellular partners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Unusual codon usage of HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Blockade of human immunodeficiency virus type 1 expression by caveolin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

The HIV 'A' (sor) gene product is essential for virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

A novel gene of HIV-1, vpu, and its 16-kilodalton product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Optimizing heterologous expression in dictyostelium: importance of 5' codon adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

7 January 2021

Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

7 January 2021

Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.021

7 January 2021

10.1016/J.VIROL.2003.11.021

Identifiers

DOI

1 reference

21 September 2017

1 reference